DRREDDY.BO
Dr. Reddy's Laboratories Limited
BSEINREQUITY
Healthcare
DELAYED
Last price
1,175.00
▼ 6.35 (0.54%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
1,181.35
Prev close
1,181.35
Day high
1,184.95
Day low
1,174.20
Volume
28.73K
Market cap
$978.27B
P/E (TTM)
17.32
52W range
1,025.90 – 1,377.95
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
245.23M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 15, 25 | Life Insurance Corporation of India Institution- Corporation |
— | 17.14M | — | Direct |
| Sep 17, 25 | VSD Family Trust Institution- Corporation |
— | 75.63M | — | Direct |
| Sep 17, 25 | Prasad (G V) Promoter |
— | 96.10M | — | Direct |
| Sep 17, 25 | GVP Family Trust Institution- Corporation |
— | 96.10M | — | Direct |
| Jun 3, 25 | Life Insurance Corporation of India Institution- Corporation |
— | 60.19M | — | Direct |
| Jun 12, 24 | Life Insurance Corporation of India Institution- Corporation |
— | 959.09K | — | Direct |
| May 22, 24 | Reddy (Satish K) Promoter |
— | 15.13M | — | Direct |
| May 22, 24 | Prasad (G V) Promoter |
— | 19.22M | — | Direct |
| May 22, 24 | APS Trust Promoter |
— | 34.35M | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
APS Trust |
Promoter | 0 | Sale |
GVP Family Trust |
Institution- Corporation | 96.10M | Acquisition |
Life Insurance Corporation of India |
Institution- Corporation | 85.70M | Acquisition |
Prasad (G V) |
Promoter | 0 | Sale |
Reddy (Satish K) |
Promoter | 16.03M | Acquisition |
VSD Family Trust |
Institution- Corporation | 75.63M | Acquisition |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Fundamentals
Market cap$978.27B
Enterprise value$1.03T
Revenue (TTM)$345.83B
Gross profit$190.84B
EBITDA$84.79B
Net income$56.59B
EPS (TTM)$67.84
Free cash flow$13.47B
Total cash$82.59B
Total debt$67.73B
Book value / share$447.25
Shares outstanding832.57M
Float600.36M
Short % of float—
Dividend yield0.65%
Beta (5Y)0.29
Valuation & profitability ratios
Trailing P/E17.32
Forward P/E21.39
PEG ratio—
Price / sales—
Price / book2.63
EV / revenue2.96
EV / EBITDA12.09
Gross margin55.18%
Operating margin16.42%
Profit margin16.36%
Return on equity16.10%
Return on assets7.96%
Debt / equity18.03
Current ratio1.88
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $335.93B | $325.54B | $279.16B | $245.88B | +3.2% |
| Operating revenue | $335.93B | $325.54B | $279.16B | $245.88B | +3.2% |
| Cost of revenue | $158.67B | $135.11B | $115.56B | $106.54B | +17.4% |
| Gross profit | $177.26B | $190.43B | $163.61B | $139.34B | -6.9% |
| Research & development | $24.06B | $27.38B | $22.87B | $19.38B | -12.1% |
| Selling, general & admin | $106.76B | $93.87B | $77.20B | $68.03B | +13.7% |
| Total operating expense | $127.14B | $118.41B | $98.30B | $80.29B | +7.4% |
| Operating income | $50.12B | $72.01B | $65.31B | $59.05B | -30.4% |
| Net interest income | -$12.00M | -$152.00M | $567.00M | -$248.00M | +92.1% |
| Pre-tax income | $54.82B | $76.78B | $71.87B | $60.37B | -28.6% |
| Tax provision | $12.35B | $19.54B | $16.19B | $15.30B | -36.8% |
| Net income | $42.85B | $56.54B | $55.68B | $45.07B | -24.2% |
| Net income to common | $42.85B | $56.54B | $55.68B | $45.07B | -24.2% |
| EBIT | $58.55B | $79.61B | $73.58B | $61.80B | -26.5% |
| EBITDA | $79.16B | $96.67B | $88.42B | $74.43B | -18.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.37B | $14.65B | $7.11B | $5.78B | — | +4.9% |
| Cash & short-term investments | $87.81B | $57.91B | $81.47B | $61.80B | — | +51.6% |
| Accounts receivable | $101.22B | $90.42B | $80.30B | $72.48B | — | +11.9% |
| Inventory | $76.53B | $71.08B | $63.55B | $48.67B | — | +7.7% |
| Total current assets | $301.98B | $250.11B | $248.05B | $204.25B | — | +20.7% |
| Property, plant & equipment | $115.93B | $97.76B | $76.89B | $66.46B | — | +18.6% |
| Goodwill & intangibles | $117.95B | $108.61B | $41.20B | $35.09B | — | +8.6% |
| Total assets | $579.35B | $492.99B | $387.52B | $321.85B | — | +17.5% |
| Total current liabilities | $167.57B | $130.39B | $96.04B | $85.84B | — | +28.5% |
| Current debt | $62.93B | $38.05B | $12.72B | $11.19B | — | +65.4% |
| Long-term debt | $12.20B | $3.80B | $3.80B | — | $3.80B | +221.1% |
| Total debt | $77.34B | $46.77B | $20.02B | $13.47B | — | +65.4% |
| Total liabilities | $198.89B | $155.82B | $106.97B | $90.86B | — | +27.6% |
| Retained earnings | $351.98B | $315.79B | $265.26B | $215.59B | — | +11.5% |
| Shareholder equity | $377.06B | $333.39B | $280.55B | $230.99B | — | +13.1% |
| Working capital | $134.41B | $119.72B | $152.01B | $118.41B | — | +12.3% |
| Net tangible assets | $259.11B | $224.78B | $239.35B | $195.90B | — | +15.3% |
| Shares issued | 834.66M | 834.46M | 834.09M | 832.64M | — | +0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $42.47B | $57.24B | $55.68B | $45.07B | -25.8% |
| Depreciation & amortisation | $20.61B | $17.06B | $14.84B | $12.64B | +20.8% |
| Stock-based compensation | $326.00M | $424.00M | $407.00M | $397.00M | -23.1% |
| Change in working capital | -$11.64B | -$29.99B | -$20.18B | -$7.86B | +61.2% |
| Operating cash flow | $56.76B | $46.43B | $45.43B | $58.88B | +22.2% |
| Capital expenditure | -$38.42B | -$34.40B | -$27.43B | -$18.87B | -11.7% |
| Investing cash flow | -$65.51B | -$58.08B | -$40.28B | -$41.37B | -12.8% |
| Share buybacks | $0 | -$1.39B | $0 | $0 | +100.0% |
| Dividends paid | -$6.66B | -$6.66B | -$6.65B | -$4.98B | +0.0% |
| Financing cash flow | $8.29B | $18.91B | -$3.76B | -$26.86B | -56.2% |
| Free cash flow | $18.33B | $12.03B | $18.00B | $40.01B | +52.4% |
| End cash position | $15.37B | $14.59B | $7.11B | $5.78B | +5.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $80.70B | $75.16B | $87.27B | $88.05B | $85.45B | — | +7.4% |
| Operating revenue | $80.70B | $75.16B | $87.27B | $88.05B | $85.45B | — | +7.4% |
| Cost of revenue | $43.16B | — | — | — | — | — | — |
| Gross profit | $37.54B | $43.03B | $46.81B | $48.14B | $48.63B | — | -12.8% |
| Research & development | $5.77B | — | $6.15B | $6.20B | $6.24B | $7.26B | — |
| Selling, general & admin | $26.10B | $14.47B | $26.92B | $26.44B | $23.18B | — | +80.4% |
| Total operating expense | $34.51B | $42.21B | $32.48B | $30.27B | $31.79B | — | -18.2% |
| Operating income | $3.03B | $829.00M | $14.33B | $17.87B | $16.84B | — | +265.9% |
| Net interest income | -$256.00M | -$1.06B | -$148.00M | $5.00M | $298.00M | — | +75.8% |
| Pre-tax income | $5.53B | $2.00B | $15.43B | $18.35B | $19.05B | — | +176.7% |
| Tax provision | $1.18B | -$216.00M | $3.53B | $4.08B | $4.95B | — | +645.4% |
| Net income | $4.43B | $2.21B | $12.10B | $14.37B | $14.18B | — | +100.8% |
| Net income to common | $4.43B | $2.21B | $12.10B | $14.37B | $14.18B | — | +100.8% |
| EBIT | $6.78B | $3.05B | $16.37B | $19.26B | $19.88B | — | +122.0% |
| EBITDA | $12.15B | $8.63B | $21.59B | $24.31B | $24.64B | — | +40.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11.20B | $15.37B | $18.66B | $9.91B | $9.00B | — | -27.1% |
| Cash & short-term investments | $81.43B | $87.81B | $82.59B | $69.81B | $66.69B | — | -7.3% |
| Accounts receivable | $100.56B | $101.22B | $103.21B | $97.74B | $95.14B | — | -0.7% |
| Inventory | $80.47B | $76.53B | $79.01B | $75.82B | $75.60B | — | +5.2% |
| Total current assets | $299.33B | $301.98B | $297.55B | $279.52B | $269.90B | — | -0.9% |
| Property, plant & equipment | $115.55B | $115.93B | $115.54B | $111.98B | $102.78B | — | -0.3% |
| Goodwill & intangibles | $116.46B | $117.95B | $114.73B | $113.24B | $107.57B | — | -1.3% |
| Total assets | $575.30B | $579.35B | $562.90B | $542.00B | $519.54B | — | -0.7% |
| Total current liabilities | $157.34B | $167.57B | $158.31B | $150.93B | $142.59B | — | -6.1% |
| Current debt | $57.69B | $62.93B | $54.09B | $44.95B | $42.18B | — | -8.3% |
| Long-term debt | — | $12.20B | — | — | — | $3.80B | — |
| Total debt | $71.95B | $77.34B | $67.73B | $58.54B | $48.64B | — | -7.0% |
| Total liabilities | $188.57B | $198.89B | $187.14B | $179.92B | $165.78B | — | -5.2% |
| Retained earnings | $356.42B | $351.98B | $349.78B | $337.68B | $329.97B | — | +1.3% |
| Shareholder equity | $383.43B | $377.06B | $372.37B | $358.49B | $350.06B | — | +1.7% |
| Working capital | $141.99B | $134.41B | $139.24B | $128.59B | $127.31B | — | +5.6% |
| Net tangible assets | $266.96B | $259.11B | $257.64B | $245.25B | $242.49B | — | +3.0% |
| Shares issued | 834.95M | 834.66M | 834.63M | 834.61M | 834.58M | — | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $4.35B | $2.21B | $11.90B | $14.27B | $14.10B | +97.2% |
| Depreciation & amortisation | $5.37B | $5.58B | $5.21B | $5.05B | $4.76B | -3.7% |
| Stock-based compensation | $97.00M | $94.00M | $20.00M | $100.00M | $112.00M | +3.2% |
| Change in working capital | -$12.00B | $7.24B | -$8.13B | -$2.56B | -$8.19B | -265.8% |
| Operating cash flow | -$927.00M | $15.64B | $10.91B | $15.57B | $14.63B | -105.9% |
| Capital expenditure | -$3.70B | -$10.82B | -$7.32B | -$10.13B | -$10.15B | +65.8% |
| Investing cash flow | $3.84B | -$26.49B | -$10.29B | -$9.54B | -$19.19B | +114.5% |
| Dividends paid | $0 | $0 | $0 | -$6.66B | $0 | — |
| Financing cash flow | -$7.12B | $7.04B | $7.78B | -$5.32B | -$1.20B | -201.1% |
| Free cash flow | -$4.63B | $4.82B | $3.59B | $5.44B | $4.48B | -196.0% |
| End cash position | $11.20B | $15.37B | $18.66B | $9.91B | $9.00B | -27.1% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Dec 2025 | 14.27 | 14.77 | +3.5% |
| Sep 2025 | 17.20 | 17.87 | +3.9% |
| Jun 2025 | 18.28 | 17.02 | -6.9% |
| Mar 2025 | 17.74 | 19.84 | +11.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 15.47 | 2 | $85.76B | +0.8% |
| Next quarter | 13.63 | 2 | $89.16B | +4.3% |
| Current year | 61.49 | 29 | $343.04B | +5.4% |
| Next year | 54.92 | 32 | $355.44B | +3.6% |
Analyst targets & ownership
Mean target$1,313.16
High target$1,615.00
Low target$1,024.00
Implied upside11.76%
Analyst count38
ConsensusHOLD
Strong buy / Buy4 / 12
Hold10
Sell / Strong sell5 / 7
Held by insiders29.45%
Held by institutions51.84%
Institutions holding227
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
0.29
5Y monthly, from filing
Dividends & splits
Forward rate$8.00 / yr
Forward yield0.65%
5-year avg yield0.63%
Payout ratio11.79%
Ex-dividend dateJul 10, 2025
Next pay date—
Last split5:1
Split dateOct 28, 2024
Headlines
Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.
24/7 Wall St. · 15m ago
Walmart's $200 military smartwatch with a handy flashlight and 'unbelievable battery' is now $27
TheStreet · 17m ago
The 30-Year Treasury Now Out-Yields Dividend Stocks by 2.2 Points. History Says What Followed the Last Time.
Motley Fool · 19m ago
World No. 3 Pegula beats defending champ Swiatek to reach Cincy final
AFP · 19m ago
Top analyst sees trouble looming for SpaceX stock
TheStreet · 20m ago
IndyCars zip among iconic Washington landmarks ahead of Freedom 250
AFP · 28m ago
He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.
24/7 Wall St. · 33m ago
Judge rules Keene ICE detainee unlawfully held without bond hearing
New Hampshire Union Leader, Manchester · 34m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.